Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBeximco Pharma Regulatory News (BXP)

Share Price Information for Beximco Pharma (BXP)

Share Price is delayed by 15 minutes
Get Live Data
50.00    7.50 (17.65%)
Bid:
45.00
Ask:
55.00
Spread: 10.00 (22.222%)
Market Cap: £223.06m
BXP Live PriceLast checked at - London Stock Exchange

Intraday Beximco Pharma Share Chart

Restoration - Beximco Pharmaceuticals PLC

Today 07:30

RNS Number : 9334J
AIM
26 June 2026
 

NOTICE

 

26/06/2026 7:30am

 

RESTORATION OF TRADING ON AIM

 

BEXIMCO PHARMACEUTICALS PLC

 

Trading on AIM for the under-mentioned securities was temporarily suspended. The suspension is lifted from 26/06/2026 7:30am, the annual audited accounts having been published.

 

GLOBAL DEPOSITARY RECEIPTS (EACH REPRESENTING 1 ORDINARY SHARE OF BDT10 EACH), FULLY PAID

(B0DM5S5) (US0885792061)

 

If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0)20 3368 3551 / 3555.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
EXCFIFLRREIRFIR
Date   Source Headline
2nd Feb 20157:00 amRNSBeximco Pharma completes US FDA Audit
28th Jan 20157:00 amRNSEnters into new Loan Agreement to fund expansion
19th Jan 201512:42 pmRNSBeximco Pharma commences export to Australia
12th Dec 20147:00 amRNSAppointment of Nominated Adviser
24th Nov 20147:00 amRNSReceives GMP Approval from Health Canada
3rd Nov 20147:00 amRNSBoard Appointment
30th Oct 20147:00 amRNSFinancial Results for the Third Quarter of 2014
24th Jul 20147:00 amRNSHalf Yearly Report
14th Jul 20143:44 pmRNSPayment of Cash Dividend
4th Jul 20147:00 amRNSReceives GMP Approval from Taiwan FDA
1st Jul 201411:28 amRNSStock Dividend Issued and Total Voting Rights
23rd Jun 20147:00 amRNSAGM Statement
9th Jun 20147:30 amRNSMr. Mahbubul Alam
14th May 20147:00 amRNSFinancial Results for the First Quarter of 2014
12th May 20147:00 amRNSFinal Results
9th May 20147:00 amRNSAGM Notification
30th Apr 20147:01 amRNSNotification of Preliminary Results and AGM
22nd Apr 20147:01 amRNSMr Mohammad Abul Qasem
13th Mar 201410:13 amRNSBoard Changes
16th Jan 20142:15 pmRNSAppointment of Nominated Adviser
31st Oct 20137:00 amRNS3rd Quarter Results
1st Oct 201310:35 amRNSDr. Abdul Alim Khan
31st Jul 20137:00 amRNSHalf Year Results - 2013
17th Jul 20134:34 pmRNSShare Dividend and TVR
1st Jul 20134:30 pmRNSAGM Statement
16th May 20137:00 amRNSAGM Notification
15th May 20137:00 amRNS1st Quarter Results
14th May 20137:00 amRNSFinal Results
1st May 20137:00 amRNSNotification of Preliminary Results and AGM
4th Apr 20137:00 amRNSDirectorate Change
28th Feb 20137:00 amRNSAppointment of Corporate Broker
18th Feb 20135:13 pmRNSIssue of Equity: Share dividend admitted
11th Feb 20137:00 amRNSBeximco Pharma Enters EU Market
31st Oct 20127:00 amRNS3rd Quarter Results
31st Jul 20127:00 amRNSHalf Yearly Report
2nd Jul 20127:00 amRNSAGM Statement
18th May 20127:00 amRNSAGM Notification
16th May 20127:00 amRNS1st Quarter Results
14th May 20127:00 amRNSFinal Results
30th Apr 201212:17 pmRNSReplacement notice of AGM
30th Apr 20127:00 amRNSNotification of preliminary results and AGM
28th Oct 20117:00 amRNS3rd Quarter Results
29th Jul 20117:00 amRNSHalf Yearly Report
21st Jul 20117:00 amRNSEU GMP Certificate Received
7th Jul 20117:20 amRNSStock Dividend Issued
4th Jul 20117:00 amRNSAGM Statement
19th May 20117:00 amRNSNotice of AGM
13th May 20117:00 amRNS1st Quarter Results
12th May 20117:00 amRNSFinal Results
28th Apr 201112:48 pmRNSPrice Sensitive Information

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.